Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2
Mease, Philip J, Lertratanakul, Apinya, Anderson, Jaclyn K, Papp, Kim, Van den Bosch, Filip, Tsuji, Shigeyoshi, Dokoupilova, Eva, Keiserman, Mauro, Wang, Xin, Zhong, Sheng, McCaskill, Reva M, Zueger, Patrick, Pangan, Aileen L, Tillett, William
Published in Annals of the rheumatic diseases (01.03.2021)
Published in Annals of the rheumatic diseases (01.03.2021)
Get full text
Journal Article
Upadacitinib in Patients with Psoriatic Arthritis and Inadequate Response to Biologics: 56-Week Data from the Randomized Controlled Phase 3 SELECT-PsA 2 Study
Mease, Philip J., Lertratanakul, Apinya, Papp, Kim A., van den Bosch, Filip E., Tsuji, Shigeyoshi, Dokoupilova, Eva, Keiserman, Mauro W., Bu, Xianwei, Chen, Liang, McCaskill, Reva M., Zueger, Patrick, McDearmon-Blondell, Erin L., Pangan, Aileen L., Tillett, William
Published in Rheumatology and therapy. (01.06.2021)
Published in Rheumatology and therapy. (01.06.2021)
Get full text
Journal Article
Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials
Burmester, Gerd R., Winthrop, Kevin, Blanco, Ricardo, Nash, Peter, Goupille, Philippe, Azevedo, Valderilio F., Salvarani, Carlo, Rubbert-Roth, Andrea, Lesser, Elizabeth, Lippe, Ralph, Lertratanakul, Apinya, Mccaskill, Reva M., Liu, John, Ruderman, Eric M.
Published in Rheumatology and therapy. (01.04.2022)
Published in Rheumatology and therapy. (01.04.2022)
Get full text
Journal Article